| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.22 | 0.007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |